CAS 850664-21-0

Benzamide,N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-

Description:

Benzamide, N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]- is a complex organic compound characterized by its multi-functional structure, which includes a benzamide core, an imidazopyridine moiety, and various substituents such as morpholine and oxadiazole groups. This compound is typically classified as a pharmaceutical intermediate or a potential drug candidate due to its diverse functional groups that may interact with biological targets. Its molecular structure suggests potential applications in medicinal chemistry, particularly in the development of therapeutics targeting specific pathways or diseases. The presence of the oxadiazole and imidazopyridine rings may contribute to its biological activity, possibly enhancing its efficacy and selectivity. Additionally, the morpholine group may influence its solubility and pharmacokinetic properties. As with many complex organic compounds, its synthesis, stability, and reactivity would be of interest in both research and industrial contexts. Safety and handling precautions should be observed due to its potential biological activity.

Formula: C₂₉H₃₀N₈O₅

GSK269962A

CAS: 850664-21-0

Formula: C₂₉H₃₀N₈O₅

Purity: 98%

Color and Shape: Solid

Molecular weight: 570.5991

Ref: IN-DA00G3OH

GSK269962A

CAS: 850664-21-0

GSK269962A

Purity: ≥98%

Molecular weight: 570.6g/mol

Ref: 54-BUP02420

GSK269962A

CAS: 850664-21-0

GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.

Formula: C₂₉H₃₀N₈O₅

Purity: 99.14% - 99.71%

Color and Shape: Solid

Molecular weight: 570.6

Ref: TM-T3518

GSK 269962

CAS: 850664-21-0

Inhibitor of Rho-associated protein kinase

Formula: C₂₉H₃₀N₈O₅

Purity: Min. 95%

Molecular weight: 570.6 g/mol

Ref: 3D-BG164808